Third-Generation Platelet Concentrates in Periodontal Regeneration: Gaining Ground in the Field of Regeneration
Platelets are important for hemostasis and the healing of wounds. In clinical settings, healing cytokines including insulin-like growth factors (IGF), platelet-derived growth factors (PDGF), and transforming growth factors (TGF) are commonly implemented. The regenerative approach in dentistry freque...
Gespeichert in:
Veröffentlicht in: | Curēus (Palo Alto, CA) CA), 2022-08, Vol.14 (8), p.e28072-e28072 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e28072 |
---|---|
container_issue | 8 |
container_start_page | e28072 |
container_title | Curēus (Palo Alto, CA) |
container_volume | 14 |
creator | Shirbhate, Unnati Bajaj, Pavan |
description | Platelets are important for hemostasis and the healing of wounds. In clinical settings, healing cytokines including insulin-like growth factors (IGF), platelet-derived growth factors (PDGF), and transforming growth factors (TGF) are commonly implemented. The regenerative approach in dentistry frequently employs platelet concentrates (PCs) that are “autologous in origin” and have a high concentration of platelets, growth factors, and leukocytes. First-generation PCs is made of platelet-rich plasma (PRP), while second-generation PC is made of platelet-rich fibrin (PRF). Both have limitations, so modification protocols and development in PRP and PRF derivatives are required for advancement mechanisms, strength, biodegradability, retention ability in the field of regenerative dentistry, and so on. As third-generation PC, newer genera kinds of PRF, such as advanced-PRF (A-PRF), advanced-PRF+ (A-PRF+), injectable-PRF (i-PRF), and titanium-PRF (T-PRF), were introduced. A-PRF matrices in their solid form were introduced using the low-speed centrifugation concept (LSCC). The applied relative centrifugal force (RCF) for A-PRF is reduced to 208 g as a result of this improved preparation process. A-PRF features a greater number of neutrophil granules in the distal region, especially at the red blood cells-buffer coat (RBC-BC) interface, and the A-PRF clot has a more porosity-like structure with a bigger interfibrous space than PRF. Since the PRF is in a gel form and is difficult to inject, i-PRF was formulated to address this problem. Compared to the other two protocols, the i-PRF protocol requires far less time, and this is the advantage of this PC. This is because i-PRF just needs the blood components to be separated, which happens within the first two to four minutes. Compared to normal L-PRF, T-PRF creates fibrin that is thicker and more densely woven. Titanium has a higher hemocompatibility than glass, which could lead to greater polymerized fibrin formation. In periodontal regenerative operations, oral surgery, and implant dentistry, PRF and its newer advanced modifications have demonstrated promising results and desirable results in both soft and hard tissue regenerative techniques. |
doi_str_mv | 10.7759/cureus.28072 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9477433</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2719655631</sourcerecordid><originalsourceid>FETCH-LOGICAL-c319t-3ffcac2c4307b34da5ee8aed70571ea9bd6f0773ebd32787b9fcaed5ba31736b3</originalsourceid><addsrcrecordid>eNpdkdFLwzAQxoMoOHRv_gEFX3ywM2napvVBkOGqMFBkPoc0uW4ZWTKTVvC_t3VjOJ_uuO93H3d8CF0RPGEsK-9k56ELk6TALDlBo4TkRVyQIj3905-jcQhrjDHpIczwCLnFSnsVV2DBi1Y7G70Z0YKBNpo6K8G2_RhCpHsBvHbK2VaY6B2Wh437qBLaaruMKu86qwa2XUE002BU5Joj-BKdNcIEGO_rBfqYPS2mz_H8tXqZPs5jSUnZxrRppJCJTClmNU2VyAAKAYrhjBEQZa3yBjNGoVY0YQWry54HldWCEkbzml6gh53vtqs3oHaPGL71eiP8N3dC82PF6hVfui9epoyllPYGN3sD7z47CC3f6CDBGGHBdYEnjORZkqc56dHrf-jadd727w1UmWdZTgfqdkdJ70Lw0ByOIZgPCfJdgvw3QfoD0iqTDg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2719655631</pqid></control><display><type>article</type><title>Third-Generation Platelet Concentrates in Periodontal Regeneration: Gaining Ground in the Field of Regeneration</title><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Shirbhate, Unnati ; Bajaj, Pavan</creator><creatorcontrib>Shirbhate, Unnati ; Bajaj, Pavan</creatorcontrib><description>Platelets are important for hemostasis and the healing of wounds. In clinical settings, healing cytokines including insulin-like growth factors (IGF), platelet-derived growth factors (PDGF), and transforming growth factors (TGF) are commonly implemented. The regenerative approach in dentistry frequently employs platelet concentrates (PCs) that are “autologous in origin” and have a high concentration of platelets, growth factors, and leukocytes. First-generation PCs is made of platelet-rich plasma (PRP), while second-generation PC is made of platelet-rich fibrin (PRF). Both have limitations, so modification protocols and development in PRP and PRF derivatives are required for advancement mechanisms, strength, biodegradability, retention ability in the field of regenerative dentistry, and so on. As third-generation PC, newer genera kinds of PRF, such as advanced-PRF (A-PRF), advanced-PRF+ (A-PRF+), injectable-PRF (i-PRF), and titanium-PRF (T-PRF), were introduced. A-PRF matrices in their solid form were introduced using the low-speed centrifugation concept (LSCC). The applied relative centrifugal force (RCF) for A-PRF is reduced to 208 g as a result of this improved preparation process. A-PRF features a greater number of neutrophil granules in the distal region, especially at the red blood cells-buffer coat (RBC-BC) interface, and the A-PRF clot has a more porosity-like structure with a bigger interfibrous space than PRF. Since the PRF is in a gel form and is difficult to inject, i-PRF was formulated to address this problem. Compared to the other two protocols, the i-PRF protocol requires far less time, and this is the advantage of this PC. This is because i-PRF just needs the blood components to be separated, which happens within the first two to four minutes. Compared to normal L-PRF, T-PRF creates fibrin that is thicker and more densely woven. Titanium has a higher hemocompatibility than glass, which could lead to greater polymerized fibrin formation. In periodontal regenerative operations, oral surgery, and implant dentistry, PRF and its newer advanced modifications have demonstrated promising results and desirable results in both soft and hard tissue regenerative techniques.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.28072</identifier><language>eng</language><publisher>Palo Alto: Cureus Inc</publisher><subject>Angiogenesis ; Anticoagulants ; Blood platelets ; Dentistry ; Electron tubes ; Epidermal growth factor ; Granulocytes ; Healthcare Technology ; Insulin-like growth factors ; Pain Management ; Plasma ; Tissue engineering ; Titanium ; Vascular endothelial growth factor ; Wound healing</subject><ispartof>Curēus (Palo Alto, CA), 2022-08, Vol.14 (8), p.e28072-e28072</ispartof><rights>Copyright © 2022, Shirbhate et al. This work is published under https://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2022, Shirbhate et al. 2022 Shirbhate et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c319t-3ffcac2c4307b34da5ee8aed70571ea9bd6f0773ebd32787b9fcaed5ba31736b3</citedby><cites>FETCH-LOGICAL-c319t-3ffcac2c4307b34da5ee8aed70571ea9bd6f0773ebd32787b9fcaed5ba31736b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477433/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477433/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Shirbhate, Unnati</creatorcontrib><creatorcontrib>Bajaj, Pavan</creatorcontrib><title>Third-Generation Platelet Concentrates in Periodontal Regeneration: Gaining Ground in the Field of Regeneration</title><title>Curēus (Palo Alto, CA)</title><description>Platelets are important for hemostasis and the healing of wounds. In clinical settings, healing cytokines including insulin-like growth factors (IGF), platelet-derived growth factors (PDGF), and transforming growth factors (TGF) are commonly implemented. The regenerative approach in dentistry frequently employs platelet concentrates (PCs) that are “autologous in origin” and have a high concentration of platelets, growth factors, and leukocytes. First-generation PCs is made of platelet-rich plasma (PRP), while second-generation PC is made of platelet-rich fibrin (PRF). Both have limitations, so modification protocols and development in PRP and PRF derivatives are required for advancement mechanisms, strength, biodegradability, retention ability in the field of regenerative dentistry, and so on. As third-generation PC, newer genera kinds of PRF, such as advanced-PRF (A-PRF), advanced-PRF+ (A-PRF+), injectable-PRF (i-PRF), and titanium-PRF (T-PRF), were introduced. A-PRF matrices in their solid form were introduced using the low-speed centrifugation concept (LSCC). The applied relative centrifugal force (RCF) for A-PRF is reduced to 208 g as a result of this improved preparation process. A-PRF features a greater number of neutrophil granules in the distal region, especially at the red blood cells-buffer coat (RBC-BC) interface, and the A-PRF clot has a more porosity-like structure with a bigger interfibrous space than PRF. Since the PRF is in a gel form and is difficult to inject, i-PRF was formulated to address this problem. Compared to the other two protocols, the i-PRF protocol requires far less time, and this is the advantage of this PC. This is because i-PRF just needs the blood components to be separated, which happens within the first two to four minutes. Compared to normal L-PRF, T-PRF creates fibrin that is thicker and more densely woven. Titanium has a higher hemocompatibility than glass, which could lead to greater polymerized fibrin formation. In periodontal regenerative operations, oral surgery, and implant dentistry, PRF and its newer advanced modifications have demonstrated promising results and desirable results in both soft and hard tissue regenerative techniques.</description><subject>Angiogenesis</subject><subject>Anticoagulants</subject><subject>Blood platelets</subject><subject>Dentistry</subject><subject>Electron tubes</subject><subject>Epidermal growth factor</subject><subject>Granulocytes</subject><subject>Healthcare Technology</subject><subject>Insulin-like growth factors</subject><subject>Pain Management</subject><subject>Plasma</subject><subject>Tissue engineering</subject><subject>Titanium</subject><subject>Vascular endothelial growth factor</subject><subject>Wound healing</subject><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNpdkdFLwzAQxoMoOHRv_gEFX3ywM2napvVBkOGqMFBkPoc0uW4ZWTKTVvC_t3VjOJ_uuO93H3d8CF0RPGEsK-9k56ELk6TALDlBo4TkRVyQIj3905-jcQhrjDHpIczwCLnFSnsVV2DBi1Y7G70Z0YKBNpo6K8G2_RhCpHsBvHbK2VaY6B2Wh437qBLaaruMKu86qwa2XUE002BU5Joj-BKdNcIEGO_rBfqYPS2mz_H8tXqZPs5jSUnZxrRppJCJTClmNU2VyAAKAYrhjBEQZa3yBjNGoVY0YQWry54HldWCEkbzml6gh53vtqs3oHaPGL71eiP8N3dC82PF6hVfui9epoyllPYGN3sD7z47CC3f6CDBGGHBdYEnjORZkqc56dHrf-jadd727w1UmWdZTgfqdkdJ70Lw0ByOIZgPCfJdgvw3QfoD0iqTDg</recordid><startdate>20220816</startdate><enddate>20220816</enddate><creator>Shirbhate, Unnati</creator><creator>Bajaj, Pavan</creator><general>Cureus Inc</general><general>Cureus</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20220816</creationdate><title>Third-Generation Platelet Concentrates in Periodontal Regeneration: Gaining Ground in the Field of Regeneration</title><author>Shirbhate, Unnati ; Bajaj, Pavan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c319t-3ffcac2c4307b34da5ee8aed70571ea9bd6f0773ebd32787b9fcaed5ba31736b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Angiogenesis</topic><topic>Anticoagulants</topic><topic>Blood platelets</topic><topic>Dentistry</topic><topic>Electron tubes</topic><topic>Epidermal growth factor</topic><topic>Granulocytes</topic><topic>Healthcare Technology</topic><topic>Insulin-like growth factors</topic><topic>Pain Management</topic><topic>Plasma</topic><topic>Tissue engineering</topic><topic>Titanium</topic><topic>Vascular endothelial growth factor</topic><topic>Wound healing</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shirbhate, Unnati</creatorcontrib><creatorcontrib>Bajaj, Pavan</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Curēus (Palo Alto, CA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shirbhate, Unnati</au><au>Bajaj, Pavan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Third-Generation Platelet Concentrates in Periodontal Regeneration: Gaining Ground in the Field of Regeneration</atitle><jtitle>Curēus (Palo Alto, CA)</jtitle><date>2022-08-16</date><risdate>2022</risdate><volume>14</volume><issue>8</issue><spage>e28072</spage><epage>e28072</epage><pages>e28072-e28072</pages><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>Platelets are important for hemostasis and the healing of wounds. In clinical settings, healing cytokines including insulin-like growth factors (IGF), platelet-derived growth factors (PDGF), and transforming growth factors (TGF) are commonly implemented. The regenerative approach in dentistry frequently employs platelet concentrates (PCs) that are “autologous in origin” and have a high concentration of platelets, growth factors, and leukocytes. First-generation PCs is made of platelet-rich plasma (PRP), while second-generation PC is made of platelet-rich fibrin (PRF). Both have limitations, so modification protocols and development in PRP and PRF derivatives are required for advancement mechanisms, strength, biodegradability, retention ability in the field of regenerative dentistry, and so on. As third-generation PC, newer genera kinds of PRF, such as advanced-PRF (A-PRF), advanced-PRF+ (A-PRF+), injectable-PRF (i-PRF), and titanium-PRF (T-PRF), were introduced. A-PRF matrices in their solid form were introduced using the low-speed centrifugation concept (LSCC). The applied relative centrifugal force (RCF) for A-PRF is reduced to 208 g as a result of this improved preparation process. A-PRF features a greater number of neutrophil granules in the distal region, especially at the red blood cells-buffer coat (RBC-BC) interface, and the A-PRF clot has a more porosity-like structure with a bigger interfibrous space than PRF. Since the PRF is in a gel form and is difficult to inject, i-PRF was formulated to address this problem. Compared to the other two protocols, the i-PRF protocol requires far less time, and this is the advantage of this PC. This is because i-PRF just needs the blood components to be separated, which happens within the first two to four minutes. Compared to normal L-PRF, T-PRF creates fibrin that is thicker and more densely woven. Titanium has a higher hemocompatibility than glass, which could lead to greater polymerized fibrin formation. In periodontal regenerative operations, oral surgery, and implant dentistry, PRF and its newer advanced modifications have demonstrated promising results and desirable results in both soft and hard tissue regenerative techniques.</abstract><cop>Palo Alto</cop><pub>Cureus Inc</pub><doi>10.7759/cureus.28072</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2168-8184 |
ispartof | Curēus (Palo Alto, CA), 2022-08, Vol.14 (8), p.e28072-e28072 |
issn | 2168-8184 2168-8184 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9477433 |
source | PubMed Central; PubMed Central Open Access |
subjects | Angiogenesis Anticoagulants Blood platelets Dentistry Electron tubes Epidermal growth factor Granulocytes Healthcare Technology Insulin-like growth factors Pain Management Plasma Tissue engineering Titanium Vascular endothelial growth factor Wound healing |
title | Third-Generation Platelet Concentrates in Periodontal Regeneration: Gaining Ground in the Field of Regeneration |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T02%3A49%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Third-Generation%20Platelet%20Concentrates%20in%20Periodontal%20Regeneration:%20Gaining%20Ground%20in%20the%20Field%20of%20Regeneration&rft.jtitle=Cur%C4%93us%20(Palo%20Alto,%20CA)&rft.au=Shirbhate,%20Unnati&rft.date=2022-08-16&rft.volume=14&rft.issue=8&rft.spage=e28072&rft.epage=e28072&rft.pages=e28072-e28072&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.28072&rft_dat=%3Cproquest_pubme%3E2719655631%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2719655631&rft_id=info:pmid/&rfr_iscdi=true |